# PSTC100 Study in Healthy Adult Subjects

> **NCT07752472** · PHASE1 · RECRUITING · sponsor: **Prospect Therapeutics (Nanjing) Limited** · enrollment: 70 (estimated)

## Conditions studied

- Healthy Adult Subjects

## Interventions

- **DRUG:** PSTC100 tablets
- **DRUG:** PSTC100 tablets

## Key facts

- **NCT ID:** NCT07752472
- **Lead sponsor:** Prospect Therapeutics (Nanjing) Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-09-01
- **Primary completion:** 2027-07-12
- **Final completion:** 2027-10-10
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2026-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07752472

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07752472, "PSTC100 Study in Healthy Adult Subjects". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07752472. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*